These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 28092083

  • 1. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.
    Bono F, Savoia P, Guglielmi A, Gennarelli M, Piovani G, Sigala S, Leo D, Espinoza S, Gainetdinov RR, Devoto P, Spano P, Missale C, Fiorentini C.
    Mol Neurobiol; 2018 Feb; 55(2):1054-1067. PubMed ID: 28092083
    [Abstract] [Full Text] [Related]

  • 2. Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer.
    Bono F, Mutti V, Savoia P, Barbon A, Bellucci A, Missale C, Fiorentini C.
    Neurobiol Dis; 2019 Sep; 129():1-12. PubMed ID: 31051233
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G, Zanetti S, Missale C, Spano P.
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [Abstract] [Full Text] [Related]

  • 5. Presynaptic and Postsynaptic Mesolimbic Dopamine D3 Receptors Play Distinct Roles in Cocaine Versus Opioid Reward in Mice.
    Xi ZX, Bocarsly ME, Galaj E, Hempel B, Teresi C, Shaw M, Bi GH, Jordan C, Linz E, Alton H, Tanda G, Freyberg Z, Alvarez VA, Newman AH.
    Biol Psychiatry; 2024 Nov 01; 96(9):752-765. PubMed ID: 38838841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J, Afonso-Oramas D, Cruz-Muros I, Salas-Hernández J, Barroso-Chinea P, Moratalla R, Millan MJ, González-Hernández T.
    Neurobiol Dis; 2015 Feb 01; 74():325-35. PubMed ID: 25511804
    [Abstract] [Full Text] [Related]

  • 8. Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling.
    Collo G, Cavalleri L, Bono F, Mora C, Fedele S, Invernizzi RW, Gennarelli M, Piovani G, Kunath T, Millan MJ, Merlo Pich E, Spano P.
    Neural Plast; 2018 Feb 01; 2018():4196961. PubMed ID: 29531524
    [Abstract] [Full Text] [Related]

  • 9. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.
    Cavalleri L, Merlo Pich E, Millan MJ, Chiamulera C, Kunath T, Spano PF, Collo G.
    Mol Psychiatry; 2018 Apr 01; 23(4):812-823. PubMed ID: 29158584
    [Abstract] [Full Text] [Related]

  • 10. Chronic activation of the D2 autoreceptor inhibits both glutamate and dopamine synapse formation and alters the intrinsic properties of mesencephalic dopamine neurons in vitro.
    Fasano C, Kortleven C, Trudeau LE.
    Eur J Neurosci; 2010 Nov 01; 32(9):1433-41. PubMed ID: 20846243
    [Abstract] [Full Text] [Related]

  • 11. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
    Zheng M, Zhang X, Sun N, Min C, Zhang X, Kim KM.
    Biochim Biophys Acta; 2016 Aug 01; 1863(8):2072-83. PubMed ID: 27188791
    [Abstract] [Full Text] [Related]

  • 12. Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism.
    Luis-Ravelo D, Fumagallo-Reading F, Castro-Hernandez J, Barroso-Chinea P, Afonso-Oramas D, Febles-Casquero A, Cruz-Muros I, Salas-Hernandez J, Mesa-Infante V, Rodriguez-Nuñez J, Gonzalez-Hernandez T.
    Pharmacol Res; 2021 Mar 01; 165():105434. PubMed ID: 33484816
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D3 receptor modulates D2 receptor effects on cAMP and GABA release at striatopallidal terminals-Modulation by the Ca2+-Calmodulin-CaMKII system.
    Villalobos-Escobedo FS, Jijón-Lorenzo R, Avalos-Fuentes JA, Paz-Bermúdez F, Recillas-Morales S, Rojas IC, Leyva-Gómez G, Cortés H, Florán B.
    Eur J Neurosci; 2024 Apr 01; 59(7):1441-1459. PubMed ID: 38151481
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
    Matsukawa N, Maki M, Yasuhara T, Hara K, Yu G, Xu L, Kim KM, Morgan JC, Sethi KD, Borlongan CV.
    Brain Res; 2007 Jul 30; 1160():113-23. PubMed ID: 17573046
    [Abstract] [Full Text] [Related]

  • 15. The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons.
    Matera C, Bono F, Pelucchi S, Collo G, Bontempi L, Gotti C, Zoli M, De Amici M, Missale C, Fiorentini C, Dallanoce C.
    Biochem Pharmacol; 2019 May 30; 163():154-168. PubMed ID: 30772268
    [Abstract] [Full Text] [Related]

  • 16. Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway.
    Mutti V, Bono F, Tomasoni Z, Bontempi L, Guglielmi A, Bolognin S, Schwamborn JC, Missale C, Fiorentini C.
    Mol Neurobiol; 2022 Apr 30; 59(4):2129-2149. PubMed ID: 35044626
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection.
    Bono F, Mutti V, Fiorentini C, Missale C.
    Biomolecules; 2020 Jul 09; 10(7):. PubMed ID: 32659920
    [Abstract] [Full Text] [Related]

  • 18. Dopamine transporter is downregulated and its association with chaperone protein Hsc70 is enhanced by activation of dopamine D3 receptor.
    Chang PK, Chien KY, Chen JC.
    Brain Res Bull; 2020 Dec 09; 165():263-271. PubMed ID: 33049353
    [Abstract] [Full Text] [Related]

  • 19. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.
    Zhao W, Huang Y, Liu Z, Cao BB, Peng YP, Qiu YH.
    PLoS One; 2013 Dec 09; 8(6):e65860. PubMed ID: 23799052
    [Abstract] [Full Text] [Related]

  • 20. New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion.
    Farino ZJ, Morgenstern TJ, Maffei A, Quick M, De Solis AJ, Wiriyasermkul P, Freyberg RJ, Aslanoglou D, Sorisio D, Inbar BP, Free RB, Donthamsetti P, Mosharov EV, Kellendonk C, Schwartz GJ, Sibley DR, Schmauss C, Zeltser LM, Moore H, Harris PE, Javitch JA, Freyberg Z.
    Mol Psychiatry; 2020 Sep 09; 25(9):2070-2085. PubMed ID: 30626912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.